Composition comprising recombinant nucleic acid encoding Sox2, Oct-4, Nanog and Lin28
The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.
1. A composition comprising recombinant nucleic acid encoding potency-determining factors SOX2, OCT-4, NANOG, and LIN28, the factor-encoding nucleic acid being operably linked to at least one heterologous promoter, wherein the composition induces reprogramming when introduced into a mammalian cell.
2. A composition of claim 1 , wherein a single molecule comprises the nucleic acid encoding the potency-determining factors.
3. A composition of claim 1 , wherein a plurality of molecules comprise the nucleic acid encoding the potency-determining factors.
4. A composition of claim 1 , wherein the promoter does not promote transcription in reprogrammed mammalian cell.
5. A composition of claim 1 , further comprising a selectable marker.
6. A composition of claim 5 , wherein the marker is a gene that encodes a protein selected from the group consisting of Green Fluorescent Protein, Enhanced Green Fluorescent Protein, and luciferase.
7. A composition of claim 5 , further comprising a promoter operably linked to the marker, the promoter being selectively active in the mammalian cell after being reprogrammed to pluripotency.
8. A composition of claim 5 , wherein the marker is flanked by removal elements.
9. A composition of claim 8 , wherein the elements are Cre recombinase recognition elements.
10. A composition of claim 1 , wherein the recombinant nucleic acid does not integrate into the genome of the mammalian cell when introduced to the cell.
11. A composition of claim 1 , wherein the recombinant nucleic acid comprises a retroviral vector.
12. A composition of claim 11 , wherein the retroviral vector is a lentiviral vector.
13. A composition of claim 1 , wherein the nucleic acid is contained in virions.
14. A transgenic mammalian euploid cell comprising a recombinant genetic construct encoding potency-determining factors SOX2, OCT-4, NANOG, and LIN28 that induces reprogramming of the mammalian cell.
15. A kit for cellular reprogramming, the kit comprising:
nucleic acid encoding SOX2,
nucleic acid encoding OCT-4;
nucleic acid encoding NANOG;
nucleic acid encoding LIN28 and a heterologous promoter operably linked to at least one of the nucleic acid encoding SOX2, nucleic acid encoding OCT-4, nucleic acid encoding NANOG, and nucleic acid encoding LIN28.
16. The kit of claim 15 , wherein at least one of the nucleic acid encoding SOX2, nucleic acid encoding OCT-4, nucleic acid encoding NANOG, and nucleic acid encoding LIN28 are on a genetic construct.